Page 1

Aptar Aptar Reports Third Quarter 2021 Results Crystal Lake , Illinois , October 28 , 2021 -- AptarGroup , Inc. ( NYSE : ATR ) , a global leader in drug delivery , consumer product dispensing and active material science solutions , today reported third quarter results for 2021 . Third Quarter 2021 Summary • Reported sales grew 9 % , primarily driven by double - digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth • Core sales ( excluding currency effects ) increased 8 % • • • Pharma sales declined slightly compared to the prior year Reported earnings per share totaled $ 0.70 and included restructuring charges ( $ 0.12 ) , an unrealized loss on an equity investment ( $ 0.10 ) resulting from the mark - to - market position of our investment in PureCycle Technologies , Inc. ( purification recycling technology ) and acquisition costs ( $ 0.02 ) Adjusted earnings per share , excluding restructuring charges , the loss on the equity investment and acquisition costs , totaled $ 0.94 • Reported net income totaled $ 47 million • Adjusted EBITDA totaled $ 154 million • Acquisition Updates : Completed the acquisition of 80 % of Weihai Hengyu Medical Products , adding elastomeric and plastic component manufacturing capabilities in China for injectable drug delivery O Completed the acquisition of a majority stake in Voluntis , a provider of digital therapeutic solutions Third Quarter Results For the quarter ended September 30 , 2021 , reported sales increased 9 % to $ 825 million compared to $ 759 million in the prior year . Core sales , excluding the impact from changes in currency exchange rates , increased 8 % . 1